Fact CheckerSign in

NCT06813417Active, not recruitingEarly phase 1

CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma

An Open Label Individual Patient Dose Escalation Study Investigating the Safety and Efficacy of Retreatment With GCAR1 in a Patient With Multiply Relapsed Alveolar Soft Part Sarcoma

Source: ClinicalTrials.gov · Last updated 10 Apr 2025

Brief summary (registry, in English)

A single patient study to determine whether GCAR1 is safe and effective for re-treatment of alveolar soft part sarcoma (ASPS) with GPNMB surface expression that has relapsed and is not responding to usual treatment.

Status (registry)
Active, not recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
1 (actual)
First submitted
28 Jan 2025
Start date
30 Jan 2025
Primary completion date
30 Jan 2030
Lead sponsor
University of Calgary
NCT number
NCT06813417

What you commit to

  • Study type: Interventional · Early phase 1
  • Participants enrolled: 1
  • From 30 Jan 2025 to the primary completion date, 30 Jan 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Anti-cancer therapy within 21 calendar days prior to the first dose of lymphodepleting chemotherapy. If subject has received anti-cancer therapy, they must have recovered adequately from the toxicity and/or complications from the intervention prior to starting therapy as per the discretion of the Qualified Investigator/Co-Investigator

Other illness

  • Any active uncontrolled infection

Other

  • Pregnancy or nursing

Who the study is looking for

  • The patient must provide informed consent
  • Adequate organ function, defined as creatinine clearance \>30 ml/min and LVEF \>45%

Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Arthur J.E. Child Comprehensive Cancer Centre
Coordinator of this site? Confirm its status
CalgaryCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.